Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Clinical
NovaBay Pharmaceuticals to Hold Third Quarter 2020 Conference Call on November…
Clinical
OliX Pharmaceuticals Announces FDA Clearance of the IND to Evaluate the…
Commercial
BioSpace Movers & Shakers, Oct. 30
Commercial
Q32 Stays Busy with $60 Million Series B and First Dose…
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Clinical
Pharma Industry News and Analysis – FirstWord Pharma – Benefits
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Clearside Biomedical to Report Third Quarter 2020 Financial Results and Provide…
Commercial
Oyster Point Pharma to Report Third Quarter 2020 Financial Results on…
Clinical
Iovance Biotherapeutics to Host Third Quarter 2020 Financial Results Conference Call…
Clinical
Trevena, Inc. Announces DEA Scheduling of OLINVYK (oliceridine) injection – FirstWord…
Home
Therapy areas
Immuno-inflammation
Immuno-inflammation
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Immuno-inflammation
Johnson & Johnson reports positive results for Stelara using “treat-to-target” approach in Phase III Crohn’s disease trial
Firstwordpharma News
-
February 14, 2020
Immuno-inflammation
Physician Views snap poll: AbbVie builds out clinical case for Rinvoq in psoriatic arthritis; how do rheumatologists perceive the data?
Immuno-inflammation
AbbVie’s SKYRIZI Now Publicly Reimbursed in Ontario, Alberta, Saskatchewan and Quebec for the Treatment of Moderate to Severe Plaque Psoriasis
Immuno-inflammation
Atlantic Healthcare Hosts Key Opinion Leader Discussion on Unmet Medical Need in Ulcerative Colitis and the Advantages of Alicaforsen
Immuno-inflammation
Penn Researchers Identify Cancer Cell Defect Driving Resistance to CAR T Cell Therapy
Immuno-inflammation
Discovery would allow researchers to fine-tune CAR-T activity
Firstwordpharma News
-
January 30, 2020
0
Immuno-inflammation
Hansa Biopharma Completes Enrollment in Anti-GBM
Biospace News
-
January 27, 2020
0
Immuno-inflammation
Drug profiling and gene scissors open new avenues in immunotherapy
Firstwordpharma News
-
January 22, 2020
0
Immuno-inflammation
ICER Issues Final Report and Policy Recommendations on JAK Inhibitors for...
Firstwordpharma News
-
January 9, 2020
0
Immuno-inflammation
Durect Drug Fails to Shine in Mid-Stage Plaque Psoriasis Trial
Biospace News
-
January 3, 2020
0
1
2
3
...
7
Page 1 of 7
- Advertisement -
MOST POPULAR
Anixa Biosciences and Moffitt Cancer Center Announce Completion of Viral Vector...
February 12, 2020
Scottish Medicines Consortium pembrolizumab (Keytruda)
June 13, 2019
BioArctic presents Nomination Committee and publishes financial calendar 2020
November 5, 2019
Aurinia Pharmaceuticals to Present at the 9th Annual SVB Leerink Global...
February 21, 2020
Load more
HOT NEWS
Commercial
BerGenBio ASA: Invitation to First Quarter Presentation and Webcast
Commercial
Alladapt Immunotherapeutics Secures $60 Million in Series C Financing for Development...
Commercial
Alcon to Officially Spin out From Novartis on April 9
Others
Legal Decision Could Open the Doors for Truvada Generic Competition One...
